<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 19 Nov 2026 14:20:56 -0500--><rss version="2.0">
    <channel>
        <title>Avalo Therapeutics, Inc. (AVTX) Press Releases</title>
        <link>https://ir.avalotx.com/news-events-presentations/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_ea697aa916e28469528b0006da59afb9/avalotx/files/theme/images/logo-sm.png</url>
                <title>Avalo Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/236/avalo-therapeutics-reports-third-quarter-2026-financial-results-and-recent-business-updates</link>
                <pubDate>Thu, 05 Nov 26 07:00:00 -0500</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/236/avalo-therapeutics-reports-third-quarter-2026-financial-results-and-recent-business-updates</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics to Participate in Upcoming Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/235/avalo-therapeutics-to-participate-in-upcoming-investor-conferences</link>
                <pubDate>Mon, 02 Nov 26 16:00:00 -0500</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/235/avalo-therapeutics-to-participate-in-upcoming-investor-conferences</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/234/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4</link>
                <pubDate>Tue, 29 Sep 26 16:01:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/234/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/233/avalo-therapeutics-to-present-at-the-european-academy-of-dermatology-and-venereology-eadv-2026-congress</link>
                <pubDate>Wed, 23 Sep 26 07:00:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/233/avalo-therapeutics-to-present-at-the-european-academy-of-dermatology-and-venereology-eadv-2026-congress</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/232/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4</link>
                <pubDate>Fri, 04 Sep 26 16:05:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/232/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics to Participate in Upcoming Investor Conferences]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/231/avalo-therapeutics-to-participate-in-upcoming-investor-conferences</link>
                <pubDate>Thu, 03 Sep 26 07:00:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/231/avalo-therapeutics-to-participate-in-upcoming-investor-conferences</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/230/avalo-therapeutics-reports-second-quarter-2026-financial-results-and-recent-business-updates</link>
                <pubDate>Thu, 06 Aug 26 07:00:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/230/avalo-therapeutics-reports-second-quarter-2026-financial-results-and-recent-business-updates</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics to Participate in the BTIG Biotechnology Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/229/avalo-therapeutics-to-participate-in-the-btig-biotechnology-conference</link>
                <pubDate>Wed, 22 Jul 26 07:00:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/229/avalo-therapeutics-to-participate-in-the-btig-biotechnology-conference</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/228/avalo-therapeutics-to-participate-in-the-leerink-partners-therapeutics-forum</link>
                <pubDate>Tue, 07 Jul 26 07:00:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/228/avalo-therapeutics-to-participate-in-the-leerink-partners-therapeutics-forum</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.avalotx.com/news-events-presentations/press-releases/detail/227/avalo-therapeutics-to-join-the-russell-2000-and-russell-3000-indexes</link>
                <pubDate>Fri, 26 Jun 26 07:00:00 -0400</pubDate>
                <guid>https://ir.avalotx.com/news-events-presentations/press-releases/detail/227/avalo-therapeutics-to-join-the-russell-2000-and-russell-3000-indexes</guid>
                                                                            </item>
            </channel>
</rss>